- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
HCW Biologics Inc (HCWB)
HCW Biologics Inc stock price live, this page displays NASDAQ HCWB stock exchange data. View the HCWB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the HCW Biologics Inc real time stock price chart below.
What Is the HCW Biologics Inc Stock Price Today?
The HCW Biologics Inc stock price today is 4.240.
What Is the Stock Symbol for HCW Biologics Inc?
The stock symbol for HCW Biologics Inc is ""HCWB.""
What Stock Exchange Does HCW Biologics Inc Trade On?
HCW Biologics Inc is listed and trades on the NASDAQ stock exchange.
Is HCW Biologics Inc a Good Stock to Buy?
Determining whether HCW Biologics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HCWB quote. (ISIN: US40423R2040)
What Is the HCW Biologics Inc Stock Price Today?
The HCW Biologics Inc stock price today is 4.240.
What Is the Stock Symbol for HCW Biologics Inc?
The stock symbol for HCW Biologics Inc is ""HCWB.""
What Stock Exchange Does HCW Biologics Inc Trade On?
HCW Biologics Inc is listed and trades on the NASDAQ stock exchange.
Is HCW Biologics Inc a Good Stock to Buy?
Determining whether HCW Biologics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HCWB quote. (ISIN: US40423R2040)
NASDAQ
Currency in USD
4.240
-0.060(-1.40%)
Closed·
After Hours
4.110-0.130(-3.07%)
·
Fair Value
An estimate of a HCW Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.200
4.340
52 wk Range
3.550
100.800
HCWB Scorecard
Full Analysis
Operates with a significant debt burden
HCWB is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a HCW Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.2004.340
52 wk Range
3.550100.800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HCWB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a HCW Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
35.000
Upside
+725.47%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Form 8K HCW Biologics Inc For: 1 July
- Investing.com
- Form 8K HCW Biologics Inc For: 1 July
- Investing.com
- Form 8K HCW Biologics Inc For: 26 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
HCW Biologics Inc Company Profile
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company’s lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in phase 1 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201 and HCW9206, novel immunotherapeutic for memory-like natural killer cells, cancer, and pathogens; HCW11-006, an immune cell stimulator; HCW11-002 and HCW11-0027, which are immune checkpoint inhibitors to treat oncology and other senescence-associated indications; and HCW11-018, a fusions and immune cell engagers to treat cancer. The company has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecules. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.
Compare HCWB to Peers and Sector
Metrics to compare | HCWB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHCWBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −4.0x | −0.5x | |
PEG Ratio | −0.02 | −0.17 | 0.00 | |
Price/Book | −0.9x | 1.8x | 2.6x | |
Price / LTM Sales | 5.4x | 9.4x | 3.2x | |
Upside (Analyst Target) | - | 65.8% | 43.8% | |
Fair Value Upside | Unlock | 20.1% | 8.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 35.000
(+725.47% Upside)
Earnings
Latest Release
May 16, 2025
EPS / Forecast
-0.05 / --
Revenue / Forecast
5.10K / --
People Also Watch
FAQ
What Stock Exchange Does HCW Biologics Trade On?
HCW Biologics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for HCW Biologics?
The stock symbol for HCW Biologics is "HCWB."
What Is the HCW Biologics Market Cap?
As of today, HCW Biologics market cap is 7.80M.
What Is HCW Biologics's Earnings Per Share (TTM)?
The HCW Biologics EPS (TTM) is -24.35.
From a Technical Analysis Perspective, Is HCWB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has HCW Biologics Stock Split?
HCW Biologics has split 1 times.
How Many Employees Does HCW Biologics Have?
HCW Biologics has 36 employees.
What is the current trading status of HCW Biologics (HCWB)?
As of 01 Aug 2025, HCW Biologics (HCWB) is trading at a price of 4.24, with a previous close of 4.30. The stock has fluctuated within a day range of 4.20 to 4.34, while its 52-week range spans from 3.55 to 100.80.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.